Bruker (NASDAQ:BRKR) VP Mark Munch Sells 2,000 Shares

Bruker Corporation (NASDAQ:BRKR) VP Mark Munch sold 2,000 shares of the stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $52.87, for a total transaction of $105,740.00. Following the sale, the vice president directly owned 134,806 shares of the company’s stock, valued at $7,127,193.22. This represents a 1.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Bruker Trading Up 8.8%

Shares of NASDAQ BRKR traded up $4.92 during midday trading on Wednesday, reaching $60.67. The stock had a trading volume of 4,105,639 shares, compared to its average volume of 2,368,966. The firm has a market cap of $9.24 billion, a price-to-earnings ratio of -86.67, a price-to-earnings-growth ratio of 1.61 and a beta of 1.26. Bruker Corporation has a twelve month low of $30.09 and a twelve month high of $65.30. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.92 and a current ratio of 1.85. The company’s 50 day moving average price is $58.02 and its 200 day moving average price is $49.52.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Tuesday, August 4th. The medical research company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.11. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The company had revenue of $838.50 million for the quarter, compared to analyst estimates of $853.57 million. During the same period in the prior year, the firm posted $0.32 EPS. The company’s quarterly revenue was up 5.2% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, sell-side analysts expect that Bruker Corporation will post 2.12 EPS for the current year.

Bruker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Shareholders of record on Monday, September 21st will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, September 21st. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Bruker’s dividend payout ratio is -28.57%.

Institutional Trading of Bruker

Large investors have recently made changes to their positions in the company. Pallas Capital Advisors LLC acquired a new position in Bruker during the second quarter worth $570,746,000. Edmond DE Rothschild Holding S.A. bought a new position in shares of Bruker in the second quarter valued at $169,899,000. Franklin Resources Inc. grew its holdings in shares of Bruker by 317.7% during the fourth quarter. Franklin Resources Inc. now owns 2,309,404 shares of the medical research company’s stock valued at $108,796,000 after buying an additional 1,756,460 shares during the last quarter. Primecap Management Co. CA bought a new stake in shares of Bruker during the second quarter worth about $53,145,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of Bruker during the second quarter worth about $44,839,000. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

BRKR has been the subject of a number of recent analyst reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of Bruker in a report on Monday, August 31st. UBS Group assumed coverage on Bruker in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $65.00 price objective on the stock. Stifel Nicolaus set a $50.00 target price on Bruker in a research note on Wednesday, August 5th. JPMorgan Chase & Co. lifted their target price on Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a report on Monday, June 8th. Finally, TD Cowen restated a “hold” rating on shares of Bruker in a report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Bruker currently has an average rating of “Hold” and a consensus price target of $57.00.

About Bruker

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.